Submit manuscript...
MOJ
eISSN: 2573-2951

Bioequivalence & Bioavailability

Review Article Volume 5 Issue 1

Nanotechnology and it’s therapeutic application – a review

Sana Sarfaraz, Tanveer Bano, Wajeeha Fatima

Department of Pharmacy, Jinnah University for Women, Pakistan

Correspondence: Sana Sarfaraz, Department of Pharmacy, Jinnah University for Women, Karachi, Karachi–74600, Pakistan

Received: February 05, 2017 | Published: January 22, 2018

Citation: Sarfaraz S, Bano T, Fatima W. Nanotechnology and it’s therapeutic application-a review. MOJ Bioequiv Availab. 2018;5(1):24-27. DOI: 10.15406/mojbb.2018.05.00077

Download PDF

Abstract

Cancer is a disease that involves abnormal cell growth; it can also invade the neighbouring cells and other parts of the body. Treatment of cancer involves radiation therapy, chemotherapy and surgery. New technologies and drug treatments are always under consideration to improve the symptoms and lifespan of cancer patients. Nano–technology is a branch of technology that deals with manipulation of atoms and molecules to nano sized products for various applications. Nano–technology has its application in various fields. Nanotechnology is creating astounding results in treatment of cancer by offering fast and sensitive detection of cancer even when it occurs on a small degree of cell and destroying tumours with least damage to surrounding non–cancer cells. This new research is providing exciting possibilities involving treatments, detection and control to cancer cells.

Keywords: cancer, nano–technology, nano–tubes, quantum dots

Abbreviations

SWNT, single walled carbon nano tubes; MSH, melanocyte stimulating hormone; NIR, near infra red light rays; TNF, tumor necrosis factor; FISH, fluorescence in situ hybridization; FNAC, fine needle aspiration cytology; PET, positron emission tomography; CT, computerized tomography

Introduction

Globally, the major reason of death is Cancer.1 Cancer is the second most common reason of death in United States (US), leading cause being the cardiovascular disorders.2 The main goal of therapy for Cancer is about delivering high quantity of anti–cancer substances into sites of tumor to get uttermost efficacy and underrate the side effects to normal organs.3

Glimpse into nano–technology

Living systems are essentially comprised of building blocks which are Nano–scaled. The thickness of single unit of DNA is approx. 2.5nm,4 Protein range is 1 to 20nm while cell membrane is 6–10nm.5 Idea of nanotechnology introduced in 1959 by R. O. Feynman, a Physicist, who rFegarded Nanotech as the development which can't be avoided. The science of suppressing, identifying and managing diseases, traumatic injury, drug targeting, increasing bioavailability, analgesic effects,6 controlled drug release,7 improving human health,6 by using Nano–scaled dimensions from 1.0 to 100.0nm6 and taking benefits of exclusive properties of Nano scaled particles, is called NANO MEDICINE.

In all areas of today's science, the nano–science has recently started rapidly growing and becoming highly important offering improvements in human health, opportunities of creating money and providing incredible improvements in standards of living and well–being.8 The field of medicine, in which nano–scaled particles having dimension range in–between 1–100nm are designed as biomedical tools for research, has been revolutionized by utilizing nanotechnology in different sections of therapeutics.9 Structures, devices and materials made by nanotechnology show entirely different biological, chemical and physical properties from those produced on large scale.10 Nano–probes gelatine, Fullerenes, quantum dots,11 nanotubes, dendrimers, Nano–pores, liposomes,12 magnetic, ceramic, micelles and radio controlled are being developed as different organic and inorganic platforms of nanotechnology(Table 1).13,14

Applications

Without use of nanotechnology

With use of nanotechnology

Diagnosis

Fine needle aspiration cytology (FNAC),
biopsy, Fluorescence in situ hybridization (FISH),
immune histo chemistry used for diagnosis.

Quantum dots and Raman probe can
be used for diagnosis.

Early detection is not possible Only
in vitro detection is possible.

Early detection is possible. In vitro
and in vivo detection is possible.

Real time detection
is not possible

Real time detection
is also possible

Imaging

X-ray, CT (Computerized tomography) scan,
Magnetic resonance imaging (MRI), Positron
emission tomography (PET scan) and
Ultrasonography can be used.

Quantum dots can be used UCM (Ultrasound
contrast medium) ultrasonography can be used. Very
early detection of neo vascularization is
possible. Imaging, targeting, delivering and
monitoring is possible.

Early detection of cancer

Cytology, FNAC
and biopsy are used.

Vital optical imaging is possible
Inexpensive mass screening is possible

Drug delivery

Oral, intramuscular, intra venous,
intra-arterial drug delivery is possible.

Targeted delivery is possible to deliver
small dose, low systemic toxicity and
better and faster responses.

Table 1 Comparison of detection, imaging, diagnosis and drug delivery with and without use of nanotechnology.14

Cancer treatments using nano–technology

As Nano–scaled dimensions have the ability to enhance delivery of molecule of drug and under rate the side effects of drug and drug carrier,15 they are used as treatment of conditions like different stages of tumor, cancer, microbial infections, gene therapy and chronic hyperglycemia.16 The main superiorities of this model of treatment are these particles act as contrast medium i.e. enhances the visibility of blood vessels for diagnostic purpose and biosensors, cell culture, magnetic nano–particles and enhance renewal and growth of tissue.15 Nanostructures are being highly valued in the field of tumor imaging.17 Small size of nano particles, due to their EPR (enhanced permeability and retention effects),18 can invade tumors and leak into abnormal tumor blood vessels and accumulate in tumor tissues.19 In Pharmaceutical development, nanotechnology proved to be the most important milestone. In human, Nano particles demonstrate superlative activity against cancer in vitro.

Nano–tubes

Nano–tubes possess great firmness and strength,20 produce heat and destroy surrounding tumor cells by absorbing Near (IR) infra red light rays.21 Indium–111 radio nucleus, a labeled carbon nano–tube has been inspected to destroy tumor cells.22 The SWNT – (Single– Walled–Carbon Nano Tubes) have been investigated as new transporting agent in vitro.23 SWNTs can efficiently transport various bimolecular substances inside human cells like therapeutic agents, amino acids, proteins, DNA and intervening RNA , by means of endocytosis.24 Carbon nano–tubes have the intrinsic (NIR) near infra red light absorption property which is useful in destroying cancer slots25 and Near–IR (infra–red) photoluminescence property which is used for cell visualizing and exploring, in vitro. Physicians can perform precise molecular and cellular intervention through nano–robotic devices. Medical Nano robots have been recommended for genetological applications26 in pharmaceutical studies, clinical science, and in modern dentistry.27 It can also be applied for reoccurring atherosclerosis, boosting breathing ability, allowing near–immediate homeostasis, boosting immune system, substituting sequences of DNA in cells, healing brain damage and fixing gross cellular distress which may have occurred due to unchangeable process or by storage of biological tissues at low temperature. Active and passive are two models which are being used for targeting nano–scaled particles to specific site of tumor. Active is all about connecting the ligands to tumor specific nanoparticles.28 The basic and characteristic mass of nanoparticles and the distinctive ability of tumor vascular system are the advantage of passive targeting.29

Quantum dots

Quantum dots are shiny new semiconductor nano–crystals,30 their radiation is firm, solid, time–honored, and inextinguishable and they are being used in many different researches related to cancer cure and therapy.31 A nano–particle with biomolecules attached to its surface or conjugation of the quantum dots is regulated to target many biological markers.30

Nano shells

The Gold Nano shells, developed by West and Halas, is an additional appealing way to detect and treat cancer.30-32 These gold shells are intended to attack melanocytes by a film of melanocyte stimulating hormone (MSH). These Nano–spheres are made steady and then particularly absorbed by tumor cells via receptor–mediated endocytosis.33 It was proclaimed through a model of subcutaneous colon cancer that organized administration of gold nano–particles of 33nm in size will initiate it’s binding to tumor necrosis factor (TNF) gathered in tumors.30

Nano–bombs

Nano–bombs can destruct cancerous cells, tumor cells and vessel system around abnormal cells that nourish those diseased cells, but these bombs can be harmful for surrounding healthy cells if used in more than normal amount.21 Contrast agent super paramagnetic nano–particles are used to enhance the contrast to characterize status of lymph node in medical imaging in humans like patients with fibro adenomas, cancer in respiratory tract, Prostate cancer, endometrial cancer and cervical cancer.34 Iron oxide super paramagnetic are captivating as they have higher responsiveness to magnetism unlike gadolinium, a traditional MR contrast agent.

Liposomes

Lipid–based vehicles of this type have been put into service mainly for enhancing the dissolving capability of lipophilic drugs and for putting limit to toxicity caused by drug.35 In mid 1960s, the discovered liposome was the actual version of Nano–scaled drug targeting tool. In ovarian cancer, folate receptors over exuberance occur by the tumor tissue. The conjugation of liposomal drug with folate can be made to direct the molecule to the tumor (Table 2).36,37

Product

Description

Use

Manufacturer

MRX 952

Nano-Particle Preparation - to
Encapsulate Camptothecin Analogues

Tumors

IMA Rx Therapeutics

Targeted Nano Therapeutics (TNT)™ System

TNT with Polymer Coated Iron
Oxide Magnetic Particle

Solid Tumors

Triton Biosystems

AuroLase™

Gold Nano-Shell

Head and Neck Cancer

Nano-Spectra Biosciences Inc

INGN 401

Nanoparticle Formulation of
Tumor Suppression Gene FUS1

Lung Cancer

Introgen Therapeutics Inc

Abraxane

Albumin Bound Taxane Particles

Non-Small Cell Lung Cancer

Celgene

Doxil

Liposomal Doxorubicin

Ovarian Tumor

Ortho Biotech

Cyclosert-Camptothecin - IT 101

β-Cylcodextrin Polymer
Drug Delivery System

Solid Tumors

Calando Pharmaceuticals

Table 2 Nano- Particles used for treatment of Cancer.37

Conclusion

Especial proposition and intensive advancement antagonistic towards cancer by timely detection, prognosis, prophylaxis, distinctive treatment and medicament is provided by Nanotechnology. The utilization of nanotechnology for the treatment of cancer has meet with appreciable consideration in recent times. In future, vast prosecution of cancer nanotechnology is expected. Nanotechnology is considered as medicine of tomorrow but still there is a lot of work that can be done in this.

Acknowledgements

None.

Conflict of interest

The author declares no conflict of interest.

References

  1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER* Stat Database: Mortality–All COD, Aggregated With State, Total US (1969–2012) Bethesda.: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2015; underlying mortality data provided by National Center for Health Statistics 2015. 2017.
  2. Copeland G, Lake A, Firth R, et al. Cancer in North America: 2010–2014. Volume one: Combined Cancer Incidence for the United States, Canada and North America. USA: North American Association of Central Cancer Registries Inc; 2017. 297 p.
  3. Moghimi SM, Hunter AC, Murray JC. Long–circulating and target–specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283–318.
  4. Freitas RA. Molecular transport and sortation Nanomedicine. Landes Bioscience, Texas, Austin, USA; 1999. p. 71–92.
  5. Freitas RA. Navigation: Nanomedicine. Landes Bioscience. Texas, Austin, USA; 1999. p. 209–274.
  6. Ratner M, Ratner D. Nanotechnology: A Gentle Introduction to the Next Big Idea. Upper Saddle River. New Zealand: Prentice Hall; 2003. p. 1–133.
  7. Crommelin DJ, Storm G, Jiskoot W, et al. Nano technological approaches for the delivery of macromolecules. J Control Release. 2003;87(1–3):81–88.
  8. Roy I, Ohulchanskyy TY, Pudavar HE, et al. Ceramic–based nano particles entrapping water–insoluble photosensitizing anticancer drugs: a novel drug–carrier system for photodynamic therapy. J Am Chem Soc. 2003;125(26):7860–7865.
  9. Samuel I, Mihail C Roco, William Sims Bainbridge. Societal Implications of Nano–science and Nano–technology. Stupp Northwestern University Materials and Life Sciences Building 2225 N, Campus Drive Evanston, IL 60208. 2001. p. 1–280.
  10. Medina C, Santos–Martinez MJ, Radomski A, et al. Nano particles: pharmacological and toxicological significance. Br J Pharmacol. 2007;150(5):552–558.
  11. Bennat C, Müller–Goymann CC. Skin penetration and stabilization of formulations containing microfine titanium dioxide as physical UV filter. Int J Cosmet Sci. 2000;22(4):271–283.
  12. Singh R, Lillard JW Jr. Nano particle–based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215–223.
  13. Nasir A. Nano vehicles: topical transportation of the future. Skin Aging. 2010;18:36–40.
  14. Gandhali A Deshpande. Cancer Nanotechnology: The Recent Developments in the Cancer Therapy. Glob J Nano. 2016;1(1):555551.
  15. Saida T. Sentinel lymph node biopsy in melanoma management: its significance and potential problems. Int J Clin Oncol. 2009;14:483–484.
  16. Surendiran A, Sandhiya S, Pradhan SC, et al. Novel application of nanotechnology in medicine. Indian J Med Res. 2009;130(6):689–701.
  17. Bayindir M, Abouraddy AF, Arnold J, et al. Thermal–sensing fiber devices by multimaterialcodrawing. Adv Mater. 2005;18:845–849.
  18. Kovacevic P, Višnjić M, Vlajković M, et al. Sentinel node biopsy for skin melanoma. Plos one. 2009;66(8):657–662.
  19. Bartlett DW, Su H, Hildebrandt IJ, et al. Impact of tumor–specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci. 2007;104(39):15549–15554.
  20. Kam NW, Liu Z, Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl. 2006;45(4):577–581.
  21. Lowery AR, Gobin AM, Day ES, et al. Immunonanoshells for targeted photothermal ablation of tumor cells. Int J Nanomedicine. 2006;1(2):149–154.
  22. Alper J. Nanotubes poised to help cancer patients. NCI Alliance for Nanotechnol Cancer. 2006:8–10.
  23. Liu Z, Sun X, Nakayama N, et al. Supramolecular chemistry on water–soluble carbon nanotubes for drug loading and delivery. ACS Nano. 2007;1(1):50–56.
  24. Kam NWS, Liu Z, Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc. 2005;127(36):12492–12493.
  25. Welsher K, Liu Z, Daranciang D, et al. Selective probing and imaging of cells with single walled carbon nanotubes as near–infrared fluorescent molecules. Nano Lett. 2008;8(2):586–590.
  26. Artemov D, Mori N, Okollie B, et al. MR molecular imaging of the Her–2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med. 2003;49(3):403–408.
  27. Fahy GM. Molecular nanotechnology and its possible pharmaceutical implications. In: Bezold C, editor. 2020 visions: Health care information standards and technologies. US Pharmacopenial Convention, Rockville, USA; 1993. p. 152–159.
  28. Akerman ME, Chan WC, Laakkonen P, et al. Nanocrystal targeting in vivo. Proc Natl Acad Sci. 2002;99(20):12617–12621.
  29. Paciotti GF, Myer L, Weinreich D, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004;11(3):169–183.
  30. Tez S, Tez M. Topical application of luminescent nanoparticles for sentinel lymph node imaging. Surg Innov. 2008;15(4):334–335.
  31. Zhang C, Wang S, Xiao J, et al. Sentinel lymph node mapping by a near–infrared fluorescent heptamethine dye. Biomaterials. 2010;31(7):1911–1917.
  32. Ryman–Rasmussen JP, Riviere JE, Monteiro–Riviere NA. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci. 2006;91(1):159–165.
  33. Kherlopian AR, Song T, Duan Q, et al. A review of imaging techniques for systems biology. BMC Syst Biol. 2008;2:74.
  34. Reilly RM. Carbon nanotubes: potential benefits and risks of nanotechnology in nuclear medicine. J Nucl Med. 2007;48(7):1039–1042.
  35. Leuschner C, Kumar C, Urbina MO, et al. The use of ligand conjugated supraparamagnetic iron oxide nanoparticles for early detection of metastasis. NSTI Nanotechnol. 2005;1:5–6.
  36. Chawla JS, Amiji MM. Biodegradable poly (epsilon–caprolactone) nanoparticles for tumor–targeted delivery of tamoxifen. Int J Pharm. 2002;249(1–2):127–138.
  37. Huang Z, Chen H, Chen ZK, et al. International nanotechnology development in 2003: Country, institution, and technology field analysis based on USPTO patent database. Journal of Nanoparticle Research. 2004;6(4):325–354.
Creative Commons Attribution License

©2018 Sarfaraz, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.